Cargando…

M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY

Abstract not included.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234202/
http://dx.doi.org/10.1093/schbul/sbaa030.357
_version_ 1783535710840553472
collection PubMed
description Abstract not included.
format Online
Article
Text
id pubmed-7234202
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72342022020-05-23 M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY Schizophr Bull Poster Session II Abstract not included. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234202/ http://dx.doi.org/10.1093/schbul/sbaa030.357 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session II
M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title_full M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title_fullStr M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title_full_unstemmed M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title_short M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
title_sort m45. efficacy and safety of the asenapine transdermal patch, hp-3070 (secuado©), for schizophrenia: a phase 3, randomized, placebo-controlled, inpatient study
topic Poster Session II
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234202/
http://dx.doi.org/10.1093/schbul/sbaa030.357